Download PDF
Thromb Haemost 2000; 83(04): 634-635
DOI: 10.1055/s-0037-1613879
Letters to the Editor
Schattauer GmbH

Recombinant Factor VIIa for Bleeding in Refractory Thrombocytopenia

Brynjar Vidarsson
1   From the Department of Hematology, Landspitalinn National University Hospital, Reykjavik, Iceland
,
Páll T. Önundarson
1   From the Department of Hematology, Landspitalinn National University Hospital, Reykjavik, Iceland
› Author Affiliations
Further Information

Publication History

Received 15 November 1999

Accepted 29 November 1999

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Tengborn L, Petruson B. A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant facor VIIa. Thromb Haemost 1996; 75: 981-2.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Peters M, Heijboer H. Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa. Thromb Haemost 1998; 80: 352.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Meijer K, Sieders E, Slooff MJH, de Wolf JTM, van der MEER J. Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.
    PubMedGoogle Scholar
  • 4 Revesz T, Arets B, Bierings M, van den Bos C. Recombinant factor VIIa in severe uremic bleeding. Thromb Haemost 1998; 80: 353.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist U, Johansson J, Glazer S, Hedner U. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26 (Suppl. 01) 159-64 6.
    PubMedGoogle Scholar
  • 6 Weiss HJ, Lages B. Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds. Blood 1988; 71: 629-35.
    PubMedGoogle Scholar